DK2379580T3 - Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner - Google Patents

Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner

Info

Publication number
DK2379580T3
DK2379580T3 DK09795876.3T DK09795876T DK2379580T3 DK 2379580 T3 DK2379580 T3 DK 2379580T3 DK 09795876 T DK09795876 T DK 09795876T DK 2379580 T3 DK2379580 T3 DK 2379580T3
Authority
DK
Denmark
Prior art keywords
antibacterial agents
treating gram
positive infections
unknown
unknown antibacterial
Prior art date
Application number
DK09795876.3T
Other languages
English (en)
Inventor
Andre Lee Pearson
Chester A Metcalf Iii
Jing Li
Original Assignee
Cubist Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc
Application granted granted Critical
Publication of DK2379580T3 publication Critical patent/DK2379580T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK09795876.3T 2008-12-22 2009-12-18 Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner DK2379580T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13987508P 2008-12-22 2008-12-22
PCT/US2009/068747 WO2010075215A1 (en) 2008-12-22 2009-12-18 Novel antibacterial agents for the treatment of gram positive infections

Publications (1)

Publication Number Publication Date
DK2379580T3 true DK2379580T3 (da) 2014-01-20

Family

ID=41718893

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09795876.3T DK2379580T3 (da) 2008-12-22 2009-12-18 Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner

Country Status (27)

Country Link
US (3) US8507647B2 (da)
EP (2) EP2674437A1 (da)
JP (1) JP5670914B2 (da)
KR (1) KR101717795B1 (da)
CN (1) CN102325787B (da)
AR (1) AR074833A1 (da)
AU (1) AU2009330245C1 (da)
BR (1) BRPI0923567A2 (da)
CA (1) CA2747965C (da)
CY (1) CY1114883T1 (da)
DK (1) DK2379580T3 (da)
ES (1) ES2442167T3 (da)
HK (1) HK1161886A1 (da)
HR (1) HRP20131170T1 (da)
IL (1) IL213638A0 (da)
MX (1) MX2011006803A (da)
NZ (1) NZ594019A (da)
PL (1) PL2379580T3 (da)
PT (1) PT2379580E (da)
RS (1) RS53152B (da)
RU (1) RU2512396C2 (da)
SG (1) SG172299A1 (da)
SI (1) SI2379580T1 (da)
SM (1) SMT201400037B (da)
TW (1) TWI444198B (da)
WO (1) WO2010075215A1 (da)
ZA (1) ZA201104693B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013013760A (es) 2011-05-26 2014-01-08 Cubist Pharm Inc Composiciones de cb-183, 315 y metodos relacionados.
US10377699B2 (en) * 2013-11-06 2019-08-13 The University Of Hong Kong Daptomycin analogues and a method for the preparation of daptomycin or a daptomycin analogue
WO2015172047A1 (en) * 2014-05-08 2015-11-12 Merck Sharp & Dohme Corp. Cyclic peptide compounds and related methods, salts and compositions
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
US11667674B2 (en) * 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
CR20180499A (es) * 2016-04-22 2019-01-25 Astrazeneca Ab Inhibidores de mcl1 macrocicliclos para tratar el cancer
US10098890B2 (en) 2016-10-29 2018-10-16 Cipla Limited Stable carfilzomib formulations
IT201600127655A1 (it) 2016-12-16 2018-06-16 Gnosis Spa Processo per la purificazione di antibiotici lipopolipeptidici
US10072045B1 (en) 2017-06-26 2018-09-11 Ramapo Pharmaceuticals, Inc. Antibacterial lipopeptides and methods for their preparation and use
US10526343B2 (en) 2018-03-26 2020-01-07 University Of Sharjah Heterocyclic systems and pharmaceutical applications thereof
RU2762182C1 (ru) * 2020-12-08 2021-12-16 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Гауземицины А и В - гликолипопептидные антибактериальные антибиотики и способ их получения

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
USRE32455E (en) 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
USRE32333E (en) 1978-10-16 1987-01-20 Eli Lilly And Company A-21978 Antibiotics and process for their production
IE55221B1 (en) 1982-02-27 1990-07-04 Beecham Group Plc Antibacterial 1-normon-2-yl-heterocyclic compounds
USRE32311E (en) * 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4399067A (en) * 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4396543A (en) * 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4537717A (en) 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
USRE32310E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4482487A (en) 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
US4524135A (en) * 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
DD238068A5 (de) 1984-10-09 1986-08-06 ���@�����@�K@�������k�� Verfahren zur herstellung von derivaten der cyclopeptidantibiotika a-21978 c
CA1315229C (en) * 1987-06-10 1993-03-30 Patrick J. Baker Chromatographic purification process
US5039660A (en) 1988-03-02 1991-08-13 Endocon, Inc. Partially fused peptide pellet
EP0460882B1 (en) * 1990-06-07 1996-07-24 Eli Lilly And Company Lipopeptide deacylase
EP0712405A1 (en) 1993-08-13 1996-05-22 Smithkline Beecham Plc Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69739532D1 (de) 1996-03-08 2009-09-24 Astellas Pharma Inc Prozess für die deacylierung von zyklischen lipopeptiden.
DE19807972A1 (de) * 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
PL206091B1 (pl) 1998-09-25 2010-06-30 Cubist Pharmaceuticals Zastosowania daptomycyny
JP2003520353A (ja) 1999-11-03 2003-07-02 ザ ウィタカー コーポレーション マルチファイバアレー用光電子モジュール
EP2295444A3 (en) * 1999-12-15 2011-03-23 Cubist Pharmaceutical Inc. Lipopeptides as antibacterial agents
MXPA02006030A (es) 1999-12-15 2004-08-23 Cubist Pharm Inc Lipopeptidos como agentes antibacterianos.
MXPA02006028A (es) * 1999-12-15 2004-08-23 Cubist Pharm Inc Lipopeptidos novedosos como agentes antibacterianos.
US20060014674A1 (en) * 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
DE60232158D1 (de) 2001-08-06 2009-06-10 Cubist Pharm Inc Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
WO2006110185A2 (en) * 2004-11-12 2006-10-19 Cubist Pharmaceuticals, Inc. Antiinfective lipopeptides

Also Published As

Publication number Publication date
US20140073558A1 (en) 2014-03-13
TWI444198B (zh) 2014-07-11
US20100184649A1 (en) 2010-07-22
ES2442167T3 (es) 2014-02-10
JP2012513467A (ja) 2012-06-14
HRP20131170T1 (hr) 2014-01-03
IL213638A0 (en) 2011-07-31
HK1161886A1 (en) 2012-08-10
ZA201104693B (en) 2013-01-30
AU2009330245A1 (en) 2011-08-04
RU2512396C2 (ru) 2014-04-10
PL2379580T3 (pl) 2014-05-30
MX2011006803A (es) 2011-09-06
AU2009330245B2 (en) 2013-05-02
SMT201400037B (it) 2014-05-07
RU2011130278A (ru) 2013-01-27
SG172299A1 (en) 2011-07-28
EP2674437A1 (en) 2013-12-18
SI2379580T1 (sl) 2014-02-28
AR074833A1 (es) 2011-02-16
US8507647B2 (en) 2013-08-13
PT2379580E (pt) 2014-01-20
CA2747965C (en) 2017-06-27
CA2747965A1 (en) 2010-07-01
US20150337013A1 (en) 2015-11-26
KR20110114592A (ko) 2011-10-19
KR101717795B1 (ko) 2017-03-17
JP5670914B2 (ja) 2015-02-18
EP2379580A1 (en) 2011-10-26
WO2010075215A1 (en) 2010-07-01
EP2379580B1 (en) 2013-10-23
BRPI0923567A2 (pt) 2016-09-27
AU2009330245C1 (en) 2013-09-26
CN102325787A (zh) 2012-01-18
NZ594019A (en) 2013-08-30
TW201028161A (en) 2010-08-01
RS53152B (en) 2014-06-30
CN102325787B (zh) 2014-05-28
CY1114883T1 (el) 2016-12-14

Similar Documents

Publication Publication Date Title
DK2379580T3 (da) Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner
SMT201500117B (it) Composti antibatterici
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
BRPI0820656A2 (pt) Tiazóis condensados antibacterianos
ATE507225T1 (de) Antibakterielle polycyclische harnstoffverbindungen
DK2331687T3 (da) Antimikrobielle midler
DE602008003471D1 (de) Schlüsselloses Zugangssystem
DK2034997T3 (da) Antibakterielle sammensætninger
BRPI0915059A2 (pt) conjunto de cateter de lavagem broncoalveolar
BRPI0919695A2 (pt) proporcionando resultados de pesquisa
BRPI0917289A2 (pt) revestimento polimérico de halo-hidrocarboneto
BR112012002628A2 (pt) "composição para tratamento de infecções por hbv"
DK2350116T3 (da) Behandling af biofilm
DK3251678T3 (da) Benzoxaborolderivater til behandling af bakterieinfektioner
BRPI0720220A2 (pt) Derivados de quinolinas antibacterianos
BR112012008061A2 (pt) compostos de oxima heterocíclica
DK2353259T3 (da) Meddelelsesforarbejdning
GB0816679D0 (en) Compounds for treating viral infections
BRPI0920895A2 (pt) compostos antibióticos de oxazolidinona tricíclica
DK2330887T3 (da) Behandlingsindretning
DK2164572T3 (da) Carbamoyl-cyclohexaner til behandling af akut mani
BRPI0823293A2 (pt) Atuador de dois estagios
DOP2010000373A (es) Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas
BRPI0917673A2 (pt) Combinação de herbicida-protetor compreendendo difluorometanossulfonilanilidas substituidas por dimetoxitriazinila
BRPI0916079A2 (pt) tratamento de água marinha residual